If such strategies prove unsuccessful in achieving affordable drug prices or regulation agreements, governments should probably implement a hierarchical reimbursement model to prioritise reimbursement and availability of more cost-effective drugs over GLP-1 RAs, such as metformin as first-line therapy and SGLT-2 inhibitors for patients with elevated cardiovascular risk
Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model
Both panic disorder and CVS follow a similar temporality pattern and share clinical signs of sympathetic nervous system activation, suggesting they can share certain pathophysiologic mechanisms.63 Different experts posit that previous adverse experiences or chronic stress can be risk factors for developing CVS,65 given that such events can affect neuronal processing and alter allostatic regulation, predisposing certain patients to the syndrome.6567 Due to the high prevalence of mood disorders in CVS, recent clinical guidelines suggest offering some type of mind-body therapy, such as meditation, relaxation therapies, or even cognitive-behavioral therapy, to the majority of patients.68 Diet-related disease Although there is currently little scientific evidence for establishing a relation between specific foods and CVS, the consumption of chocolate, cheese, and monosodium glutamate has been described as a possible trigger of CVS attacks.60,69 Curiously, those same foods have long been associated with migraine,70 and several mechanisms can explain the associations
Benedetto, R
As weight loss with any existing pharmaceutical intervention inevitably plateaus due to putative counterregulatory mechanisms, we further hypothesized that the postulated enhanced body weight suppressive effects of combined amylin- and GLP-1R-based pharmacotherapies could be even further enhanced if the drugs were introduced in a stepwise fashion, allowing the physiological systems to adjust to and overcome the tachyphylaxis that occurs with repeated drug treatments 21,22,23
